Cannabis Stock Tilray Brands Skyrockets 94.5%: Time to Buy, Sell or Hold?

Key Takeaways Tilray Brands shares soared 94.5% in three months, driven by strong Q1 results and investor optimism. TLRY's medical division expanded in Panama, Europe, and Australia through new launches and partnerships. TLRY Q1 net income improved to $1.5M from a $34.7M loss, reflecting cost control and operational efficiency. In the past three months, shares of Tilray Brands (TLRY) have skyrocketed 94.5%, significantly outperforming the industry’s 2.5% decline.Image Source: Zacks Investment ResearchTLRY s ...